Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2014 Aug 28;74(5):927–938. doi: 10.1007/s00280-014-2571-0

Table 2.

Busulfan clearance in subjects ≥ 60 years old (100103) and patients <60 years old (19808 and 10503).

CALGB Study 19808 10503 19808+10503 100103

Median age (range) 50.3(19.3–59.6) 49.6(17.8–60.0) 49.8 (17.8–60.0) 66.3 (60.3–74.3)

CL (mL/min)
 Mean 180 190 186 263
 Median 172 163 168 236
 Range 40–580 28–560 28–580 72–588
P-value* 0.0002

CL/ABW (mL/min/kg)
 Mean 2.34 2.34 2.34 3.22
 Median 2.3 2.1 2.1 3.0
 Range 0.5–4.8 0.2–5.8 0.2–5.8 1.2–6.5
P-value* 0.0001

CL/IBW (mL/min/kg)
 Mean 2.91 2.90 2.91 3.63
 Median 2.6 2.6 2.6 3.8
 Range 0.6–10.4 0.4–8.1 0.4–10.4 1.2–7
P-value* 0.0035

CL/CBW (mL/min/kg)
 Mean 2.7 2.7 2.7 3.5
 Median 2.6 2.5 2.6 3.4
 Range 0.6–8.1 0.3–8.1 1.2–6.7
P-value* 0.0005

t½ (h)
 Mean 3.88 3.93 3.91 3.70
 Median 3.00 2.77 2.82 2.62
 Range 1.05–29.4 0.28–33.0 0.28–33.0 1.24–12.4
P-value* 0.74

Vd (L)
 Mean 49.4 50.9 50.4 77.6
 Median 44.5 41.6 43.4 59.2
 Range 20.5–125 7.3–302 7.3–302 15.5–228
P-value* 0.0023
*

patients <60 years old and ≥60 years old i.e CALGB100103 vs CALGB 19808 + CALGB 10503.

ABW, actual bodyweight; IBW, ideal bodyweight, CBW, corrected bodyweight (used to dose)